vimpat

Generic: lacosamide

Labeler: ucb, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name vimpat
Generic Name lacosamide
Labeler ucb, inc.
Dosage Form INJECTION
Routes
INTRAVENOUS
Active Ingredients

lacosamide 10 mg/mL

Manufacturer
UCB, Inc.

Identifiers & Regulatory

Product NDC 0131-1810
Product ID 0131-1810_3cd293ae-29eb-ee01-e063-6294a90aff05
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA022254
DEA Schedule cv
Listing Expiration 2026-12-31
Marketing Start 2009-05-26

Pharmacologic Class

Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 01311810
Hyphenated Format 0131-1810

Supplemental Identifiers

RxCUI
809974 809984 809987 809990 809992 809994 809996 809998 810000 810002 993856 995156
UNII
563KS2PQY5
NUI
N0000008486

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name vimpat (source: ndc)
Generic Name lacosamide (source: ndc)
Application Number NDA022254 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 10 mg/mL
source: ndc
Packaging
  • 10 VIAL, GLASS in 1 CARTON (0131-1810-67) / 20 mL in 1 VIAL, GLASS
source: ndc

Packages (1)

0131-1810-67 10 VIAL, GLASS in 1 CARTON (0131-1810-67) / 20 mL in 1 VIAL, GLASS

Ingredients (1)

lacosamide (10 mg/mL)

Linked Drug Pages (1)

Vimpat ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "3cd293ae-29eb-ee01-e063-6294a90aff05", "openfda": {"nui": ["N0000008486"], "unii": ["563KS2PQY5"], "rxcui": ["809974", "809984", "809987", "809990", "809992", "809994", "809996", "809998", "810000", "810002", "993856", "995156"], "spl_set_id": ["9e79b42c-38a3-4b2c-a196-a5a1948250e2"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["UCB, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, GLASS in 1 CARTON (0131-1810-67)  / 20 mL in 1 VIAL, GLASS", "package_ndc": "0131-1810-67", "marketing_start_date": "20090526"}], "brand_name": "Vimpat", "product_id": "0131-1810_3cd293ae-29eb-ee01-e063-6294a90aff05", "dosage_form": "INJECTION", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "0131-1810", "dea_schedule": "CV", "generic_name": "lacosamide", "labeler_name": "UCB, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Vimpat", "active_ingredients": [{"name": "LACOSAMIDE", "strength": "10 mg/mL"}], "application_number": "NDA022254", "marketing_category": "NDA", "marketing_start_date": "20090526", "listing_expiration_date": "20261231"}